Back

Persistent renal dysfunction in LVAD recipients predicts increased mortality and sub-optimal reduction in pulmonary pressures.

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Management of patients with Left Ventricular Assist Device Ventricular Assist Devices ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Jeremy William

The Alfred Hospital, Melbourne (Australia)

11 More presentations in this session

Presentation thumbnail
Comparison of post-implant anticoagulation agents in left ventricular assist devices
Doctor A. Bigeh (Phoenix, US)
Abstract Slides
Presentation thumbnail
Predictors and consequences of sustained mechanical unloading in LVAD recipients.
Doctor J. William (Melbourne, AU)
Presentation thumbnail
Frequency and patterns of implantable cardiac defibrillator therapies in patients with ventricular assist devices
Doctor A. Gkouziouta (Athens, GR)
Abstract
Presentation thumbnail
Incidence and prognosis of late-onset right ventricular failure following continuous-flow left ventricular assist device implantation as bridge to transplantation
Doctor M. Ruiz Cano (Bad Oeynhausen, DE)
Abstract
Presentation thumbnail
Subclinical persistent hemolysis may affect late renal function deterioration after HeartMateII implantation
Doctor K. Iwasaki (Okayama, JP)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 2 - Management of patients with Left Ventricular Assist Device

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources